Efficacy, pharmacokinetics and safety of subcutaneous versus intravenous CT-P13 in rheumatoid arthritis: a randomized phase I/III trial
Westhovens et.al.; Rheumatology 2021;60:2277–2287
כל הפוסטים במחקרים ופרסומים
Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease
14:52
Schreiber et.al.; Gastroenterology 2021;160:2340–2353
Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysis
15:07
Caporali et.al.; Expert Rev Clin Immunol 2021 Jan;17(1):85-99